SherieLynnNovotnyMD

Psychiatry • Piscataway, NJ

Child & Adolescent Psychiatry

Assistant Professor, Psychiatry, UMDNJ-Robert Wood Johnson Medical School

Join to view full profile

Dr. Novotny is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Novotny's full profile

Already have an account?

Office
671 Hoes LN W
RM D439
Piscataway, NJ 08854
Phone+1 732-235-6800

Fax+1 732-212-0713

Education & Training

Montefiore Medical Center/Albert Einstein College of MedicineResidency, Child and Adolescent Psychiatry, 1992 - 1997
MCP-Hahnemann College of MedicineClass of 1992

Certifications & Licensure

NJ State Medical License 2003 - 2025
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Child & Adolescent Psychiatry

Clinical Trials

Galantamine Versus Placebo in Childhood Autism Start of enrollment: 2004 Apr 01
Completed
Phase 3
Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum Disorders Start of enrollment: 2007 Jan 01
Completed
Not Applicable
Efficacy of Aripiprazole Versus Placebo in the Reduction of Aggressive and Aberrant Behavior in Autistic Children Start of enrollment: 2006 May 01
Completed
Not Applicable
Developing Treatment, Treatment Validation and Treatment Scope in the Setting of an Autism Clinical Trial Start of enrollment: 2010 Nov 01
Active, not recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

10 citations
Increased repetitive behaviours and prolactin responsivity to oral m-chlorophenylpiperazine in adults with autism spectrum disorders.
Sherie Novotny, Eric Hollander, Ann T. Phillips, Andrea Allen, Stacey Wasserman
The International Journal of Neuropsychopharmacology. 2004-09-01